Registered Nurse in Branchville, NJ Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Jean Louise Schmidt, RN,BSN,IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 139 Lower North Shore Road, Branchville, NJ 07826 Phone: 973-948-0658 |
Maria S Cunico, R.N. Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4 County Road 560, Branchville, NJ 07826 Phone: 845-858-2726 Fax: 973-625-7064 |
Mrs. Susan Ann Becker, APN C Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 90 Kymer Rd, Branchville, NJ 07826 Phone: 973-386-3181 |
News Archive
Trial results show CAB LA is more effective in preventing HIV acquisition in women
The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective in preventing HIV acquisition.
Urgent action needed to better meet the needs of multiple-birth families
Having multiple-birth babies can be a time of wonder and excitement, however, according to the first-ever international collaborative report released today, these babies and their families can face serious disadvantages compared to parents of single-birth babies.
Pathway's drug development milestone triggers $4.5M tranche of Series A private equity placement
Pathway Therapeutics, a drug discovery and development company founded in New Zealand, announced that it has met an important drug development milestone triggering a US$4.5 million fourth tranche of its Series A private equity placement. The financing was led by GBS Venture Partners, Australia and CM Capital Investments, Australia with co-investors the Breast Cancer Research Trust, the Trans-Tasman Commercialisation Fund, and the New Zealand Venture Investment Firm.
Good Start Genetics to develop pre-pregnancy genetic test with completed $18M Series A financing
Good Start Genetics, Inc., today announced the completion of an $18 million Series A financing. The proceeds of this financing will be used to complete the development and launch of the Company's pre-pregnancy genetic test, which utilizes advanced DNA sequencing technology to screen for a panel of genetic disorders including those recommended by the American Congress of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG).
› Verified 3 days ago